4-MPM

4-Methylphenmetrazine (other names: 4-MPM, mephenmetrazine, PAL-747) is a stimulating designer drug derived from phenylmorpholine, analogue of phenmetrazine and 3-fluorophenmetrazine.
It is known that 4-Methylphenmetrazine (4-MPM) affects the body and causes effects similar to its related phenmetrazine compound.

History

It was first discovered in Slovenia in 2015 as an unknown stimulant.

Chemistry

4-Methylphenmetrazine is a derivative of phenylmorpholine and has a related structure to phenmetrazine and 3-fluorophenmetrazine.

Pharmacology

4-Methylphenmetrazine is a designer drug and the toxicological and pharmacological properties are not fully understood.
Studies in mice have found that 4-MPM acts on serotonin receptors and induces stimulation, energy and euphoria.

Legal status

4-Methylphenmetrazine has an unclear legal status and is positioned as a design research substance for scientific research. In some countries, it may be illegal as an analogue of phenmetrazine (in some countries where analog drugs are under control).

Technical Information:

Product Name: 4-MPM, 4-Methylphenmetrazine

Other Name(s): mephenmetrazine, PAL-747, 4-Methylphenmetrazine HCl, 4-MPM HCl

IUPAC Name: 3-methyl-2-(4-methylphenyl)morpholine

CAS: 1998216-41-3, 1094649-71-4

Molar Mass: 191.274 g•mol−1

Molecular Formula: C₁₂H₁₇NO

Formulation: A solid

NMR 4-Methylphenmetrazine

Create a preliminary purchase request. Check stock availability. Communication with support: